Atlas Trials

Study of Epratuzumab in Systemic Lupus Erythematosus

Clinical trial NCT00382837 · WITHDRAWN

Trial details

NCT number
NCT00382837
Sponsor
UCB Pharma
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2007-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.